TumCCA Cancer Research Results

TumCCA, Tumor cell cycle arrest: Click to Expand ⟱
Source:
Type:
Tumor cell cycle arrest refers to the process by which cancer cells stop progressing through the cell cycle, which is the series of phases that a cell goes through to divide and replicate. This arrest can occur at various checkpoints in the cell cycle, including the G1, S, G2, and M phases. S, G1, G2, and M are the four phases of mitosis.


Scientific Papers found: Click to Expand⟱
1450- Bos,  Cisplatin,    3-Acetyl-11-keto-β-boswellic acid (AKBA) induced antiproliferative effect by suppressing Notch signaling pathway and synergistic interaction with cisplatin against prostate cancer cells
- in-vitro, Pca, DU145
ROS↑, MMP↓, Casp↑, Apoptosis↑, Bax:Bcl2↑, TumCCA?, cycD1/CCND1↓, CDK4↓, P21↑, p27/CDKN1B↑, NOTCH↓, ChemoSen↑,
5767- CAPE,    Caffeic Acid Phenethyl Ester Is a Potential Therapeutic Agent for Oral Cancer
- Review, Oral, NA
TumCP↓, tumCV↓, TumMeta↓, Akt↓, NF-kB↓, MMPs↓, EGFR↓, COX2/PTGS2↓, TumCCA?,
3236- EGCG,  Buty,    Molecular mechanisms for inhibition of colon cancer cells by combined epigenetic-modulating epigallocatechin gallate and sodium butyrate
- in-vitro, Colon, RKO - in-vitro, Colon, HCT116 - in-vitro, Colon, HT29
Apoptosis↑, TumCCA?, HDAC1↓, DNMT1↓, survivin↓, HDAC↓, P21↑, NF-kB↑, γH2AX↑, ac‑H3↑, DNAdam↑,
9254- ISO, IH,    Isorhamnetin: what is the in vitro evidence for its antitumor potential and beyond?
- Review, Var, NA
MMP2↓, MMP9↓, MAPK↓, STAT3↓, Akt↓, mTOR↓, MEK↓, ERK↓, TumCP↓, TumCM/A↓, LDH↓, EMT↓, Casp3↑, Cyt‑c↑, BAX↑, cl‑Casp3↑, cl‑PARP↑, TumCCA?, AMPK↑, ROS↑, COX2/PTGS2↓, *cardioP↑, *hepatoP↑, *neuroP↑, *RenoP↑, *AntiViral↑, *antiCG↑, *AntiAg↑, *AntiThr↑,
8191- LGE,    Lemongrass (Cymbopogon citratus (D.C.) Stapf) Presents Antitumoral Effect and Improves Chemotherapy Activity in Prostate Cancer Cells
- in-vitro, Pca, DU145
AntiTum↑, tumCV↓, TumCP↓, ROS?, TumCCA?, selectivity↑,
8632- MBZ,    Mebendazole elicits a potent antitumor effect on human cancer cell lines both in vitro and in vivo
- vitro+vivo, Lung, NA
Apoptosis↑, TumCCA?, Cyt‑c↑, selectivity↑,
8919- MP,    Antineoplastic Effects of Mucuna pruriens Against Human Colorectal Adenocarcinoma
- in-vitro, CRC, COLO205
*AntiDiabetic↑, *antiOx↑, *antiNeop↑, antiOx↑, Dose↝, Apoptosis↑, TumCCA?,
1994- PTL,    Parthenolide Inhibits Tumor Cell Growth and Metastasis in Melanoma A2058 Cells
- in-vitro, Melanoma, A2058 - in-vitro, Nor, L929
tumCV↓, selectivity?, ROS?, BAX↑, TumCCA?, MMP2↓, MMP9↓, TumCMig↓, Synergy↑,
1458- SFN,    Sulforaphane Impact on Reactive Oxygen Species (ROS) in Bladder Carcinoma
- Review, Bladder, NA
HDAC↓, eff↓, TumW↓, TumW↓, angioG↓, *toxicity↓, GutMicro↝, AntiCan↑, ROS↑, MMP↓, Cyt‑c↑, Bax:Bcl2↑, Casp3↑, Casp9↑, Casp8∅, cl‑PARP↑, TRAIL↑, DR5↑, eff↓, NRF2↑, ER Stress↑, COX2/PTGS2↓, EGFR↓, HER2/EBBR2↓, ChemoSen↑, NF-kB↓, TumCCA?, p‑Akt↓, p‑mTOR↓, p70S6↓, p19↑, P21↑, CD44↓, CSCs↓,

Showing Research Papers: 1 to 9 of 9

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 9

Pathway results for Effect on Cancer / Diseased Cells:


Redox & Oxidative Stress(tgid=1) ⓘ

antiOx↑, 1,   NRF2↑, 1,   ROS?, 2,   ROS↑, 3,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

AMPK↑, 1,   TumCM/A↓, 1,  

Cell Death(tgid=5) ⓘ

Apoptosis↑, 4,   BAX↑, 2,   Bax:Bcl2↑, 2,   Casp↑, 1,   Casp3↑, 2,   cl‑Casp3↑, 1,   Casp8∅, 1,   Casp9↑, 1,   Cyt‑c↑, 3,   DR5↑, 1,   survivin↓, 1,   TRAIL↑, 1,  

Kinase & Signal Transduction(tgid=6) ⓘ

Akt↓, 2,   p‑Akt↓, 1,   EGFR↓, 2,   ERK↓, 1,   HER2/EBBR2↓, 1,   MAPK↓, 1,   MEK↓, 1,   mTOR↓, 1,   p‑mTOR↓, 1,   p70S6↓, 1,   STAT3↓, 1,  

Transcription & Epigenetics(tgid=7) ⓘ

DNMT1↓, 1,   ac‑H3↑, 1,   HDAC↓, 2,   HDAC1↓, 1,   tumCV↓, 3,  

Protein Folding & ER Stress(tgid=8) ⓘ

ER Stress↑, 1,  

DNA Damage & Repair(tgid=10) ⓘ

DNAdam↑, 1,   cl‑PARP↑, 2,   γH2AX↑, 1,  

Cell Cycle & Senescence(tgid=11) ⓘ

CDK4↓, 1,   cycD1/CCND1↓, 1,   p19↑, 1,   P21↑, 3,   p27/CDKN1B↑, 1,   TumCCA?, 9,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

CSCs↓, 1,   NOTCH↓, 1,   TumCP↓, 3,  

Migration(tgid=13) ⓘ

EMT↓, 1,   MMP2↓, 2,   MMP9↓, 2,   MMPs↓, 1,   TumCMig↓, 1,   TumMeta↓, 1,  

Angiogenesis & Vasculature(tgid=14) ⓘ

angioG↓, 1,  

Barriers & Transport(tgid=15) ⓘ

MMP↓, 2,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

CD44↓, 1,   COX2/PTGS2↓, 3,   NF-kB↓, 2,   NF-kB↑, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

ChemoSen↑, 2,   Dose↝, 1,   eff↓, 2,   selectivity?, 1,   selectivity↑, 2,   Synergy↑, 1,  

Clinical Biomarkers(tgid=22) ⓘ

EGFR↓, 2,   HER2/EBBR2↓, 1,   LDH↓, 1,  

Functional Outcomes(tgid=23) ⓘ

AntiCan↑, 1,   AntiTum↑, 1,   TumW↓, 2,  

Infection & Microbiome(tgid=24) ⓘ

GutMicro↝, 1,  
Total Targets: 72

Pathway results for Effect on Normal Cells:


Redox & Oxidative Stress(tgid=1) ⓘ

antiOx↑, 1,  

Transcription & Epigenetics(tgid=7) ⓘ

AntiThr↑, 1,  

Migration(tgid=13) ⓘ

AntiAg↑, 1,  

Functional Outcomes(tgid=23) ⓘ

antiCG↑, 1,   AntiDiabetic↑, 1,   antiNeop↑, 1,   cardioP↑, 1,   hepatoP↑, 1,   neuroP↑, 1,   RenoP↑, 1,   toxicity↓, 1,  

Infection & Microbiome(tgid=24) ⓘ

AntiViral↑, 1,  
Total Targets: 12

Scientific Paper Hit Count for: TumCCA, Tumor cell cycle arrest
1 Boswellia (frankincense)
1 Cisplatin
1 Caffeic Acid Phenethyl Ester (CAPE)
1 EGCG (Epigallocatechin Gallate)
1 Butyrate
1 Isorhamnetin
1 Lemongrass Extract/Citral
1 mebendazole
1 Mucuna pruriens/Velvet Bean
1 Parthenolide
1 Sulforaphane (mainly Broccoli)
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:0  prod#:%  Target#:322  State#:%  Dir#:0
wNotes=0 sortOrder:rid,rpid

 

Home Page